Menu
1-702-720-6310 info@microcapspecualtors.com

Biotech from the Bermuda Islands Brings Good News for Dementia Patients – Labiotech.eu (blog)


FierceBiotech

Biotech from the Bermuda Islands Brings Good News for Dementia Patients
Labiotech.eu (blog)
Axovant Sciences has announced positive preliminary results from a Phase II trial directed at reducing hallucinations in patients with dementia. Axovant Sciences is a biotech located in Bermuda, a British tropical island in the Atlantic ocean. From
Early win means phase 3 test is on the way for Axovant’s dementia drugFierceBiotech

all 5 news articles »

Search